Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and patient care. Visit http://www.accenture.com/newscience to learn more.
An introduction to our Patient Solution that enables Healthcare and Life Sciences organizations to provide insight-driven services and patient analytics.
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and patient care. Visit http://www.accenture.com/newscience to learn more.
An introduction to our Patient Solution that enables Healthcare and Life Sciences organizations to provide insight-driven services and patient analytics.
The Accenture Life Sciences practice helps companies pivot to the patient for best outcomes. See how we can help you. Visit https://accntu.re/2l5mUGu to learn more.
Accenture Digital Health Technology Vision 2018accenture
Explore Accenture's Digital Health Tech Vision 2018 report, showcasing five health IT trends that are going to redefine how intelligent enterprises of the future will work. Learn more: https://accntu.re/2IoOLMI
Engineering Services: con gli ingegneri per creare valore sostenibileaccenture
Collaboriamo con gli ingegneri di aziende capital intensive per combinare tecnologie innovative con un approccio pragmatico che aiuti a raggiungere risultati aziendali migliori.
Manufacturers were hard hit by COVID-19, but our research reveals the next best steps to take, based on the investments digital leaders in the industry have made and plan to make.
The Accenture Life Sciences practice helps companies pivot to the patient for best outcomes. See how we can help you. Visit https://accntu.re/2l5mUGu to learn more.
Accenture Digital Health Technology Vision 2018accenture
Explore Accenture's Digital Health Tech Vision 2018 report, showcasing five health IT trends that are going to redefine how intelligent enterprises of the future will work. Learn more: https://accntu.re/2IoOLMI
Engineering Services: con gli ingegneri per creare valore sostenibileaccenture
Collaboriamo con gli ingegneri di aziende capital intensive per combinare tecnologie innovative con un approccio pragmatico che aiuti a raggiungere risultati aziendali migliori.
Manufacturers were hard hit by COVID-19, but our research reveals the next best steps to take, based on the investments digital leaders in the industry have made and plan to make.
Genetic Technologies Limited is a diversified molecular diagnostics
company developing tools for the prediction and assessment of cancer
risk to help physicians proactively manage patient health. The
Company’s lead products, ‘GeneType for Breast Cancer’ and
‘GeneType for Colorectal Cancer’, are clinically validated risk
assessment tests that are first in their class. The Company’s
development pipeline includes new tests for COVID-19, Type 2
diabetes, cardiovascular disease, prostate cancer, and melanoma.
Listed on the ASX in 2000 and NASDAQ in 2005, Genetic
Technologies has been a leader in the development and
commercialization of genetic risk assessment technology for 20 years.
El 12 de mayo de 2017 celebramos en la Fundación Ramó Areces una jornada con IS Global y Unitaid sobre enfermedades transmitidas por vectores, como la malaria, entre otras.
Opportunity analysis of life science tools market in India - A srinivas sash...Srinivas Sashidhar
An analysis of the life science tools market in India and the market opportunity.
Please note this is a proprietary research on my views in a series of srinivas sashidhar's healthcare instinct. Your views and comments are welcome.
I am also open to individual assignments on market consulting in healthcare related markets.
You can follow my blog at https://kchsashi.blogspot.com/
Top 5 strategy of b2b supply chains trends and opportunitiesglobaltradeplaza498
B2B supply chains are experiencing significant transformations. As companies strive to stay competitive and meet the demands of their customers, they must adopt innovative strategies and leverage emerging trends. Here are the top five strategies for B2B supply chains, highlighting the trends and opportunities that can drive success.
This survey seeks to understand some of the key priorities for manufacturers as well as their strategies for growth, specifically with respect to capabilities, physical resources and human capital.
Whitepaper: Patent strategies in the 2012 economic environmentSagentia
Difficulties and changes in the macro-economic climate have forced companies to alter the way they carry out their research and development. This, in turn, has had an effect on the approach of many organisations to intellectual property.
http://www.sagentia.com/IP
Encryption in Microsoft 365 - ExpertsLive Netherlands 2024Albert Hoitingh
In this session I delve into the encryption technology used in Microsoft 365 and Microsoft Purview. Including the concepts of Customer Key and Double Key Encryption.
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
UiPath Test Automation using UiPath Test Suite series, part 4DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 4. In this session, we will cover Test Manager overview along with SAP heatmap.
The UiPath Test Manager overview with SAP heatmap webinar offers a concise yet comprehensive exploration of the role of a Test Manager within SAP environments, coupled with the utilization of heatmaps for effective testing strategies.
Participants will gain insights into the responsibilities, challenges, and best practices associated with test management in SAP projects. Additionally, the webinar delves into the significance of heatmaps as a visual aid for identifying testing priorities, areas of risk, and resource allocation within SAP landscapes. Through this session, attendees can expect to enhance their understanding of test management principles while learning practical approaches to optimize testing processes in SAP environments using heatmap visualization techniques
What will you get from this session?
1. Insights into SAP testing best practices
2. Heatmap utilization for testing
3. Optimization of testing processes
4. Demo
Topics covered:
Execution from the test manager
Orchestrator execution result
Defect reporting
SAP heatmap example with demo
Speaker:
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Tobias Schneck
As AI technology is pushing into IT I was wondering myself, as an “infrastructure container kubernetes guy”, how get this fancy AI technology get managed from an infrastructure operational view? Is it possible to apply our lovely cloud native principals as well? What benefit’s both technologies could bring to each other?
Let me take this questions and provide you a short journey through existing deployment models and use cases for AI software. On practical examples, we discuss what cloud/on-premise strategy we may need for applying it to our own infrastructure to get it to work from an enterprise perspective. I want to give an overview about infrastructure requirements and technologies, what could be beneficial or limiting your AI use cases in an enterprise environment. An interactive Demo will give you some insides, what approaches I got already working for real.
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...UiPathCommunity
💥 Speed, accuracy, and scaling – discover the superpowers of GenAI in action with UiPath Document Understanding and Communications Mining™:
See how to accelerate model training and optimize model performance with active learning
Learn about the latest enhancements to out-of-the-box document processing – with little to no training required
Get an exclusive demo of the new family of UiPath LLMs – GenAI models specialized for processing different types of documents and messages
This is a hands-on session specifically designed for automation developers and AI enthusiasts seeking to enhance their knowledge in leveraging the latest intelligent document processing capabilities offered by UiPath.
Speakers:
👨🏫 Andras Palfi, Senior Product Manager, UiPath
👩🏫 Lenka Dulovicova, Product Program Manager, UiPath
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
Connector Corner: Automate dynamic content and events by pushing a buttonDianaGray10
Here is something new! In our next Connector Corner webinar, we will demonstrate how you can use a single workflow to:
Create a campaign using Mailchimp with merge tags/fields
Send an interactive Slack channel message (using buttons)
Have the message received by managers and peers along with a test email for review
But there’s more:
In a second workflow supporting the same use case, you’ll see:
Your campaign sent to target colleagues for approval
If the “Approve” button is clicked, a Jira/Zendesk ticket is created for the marketing design team
But—if the “Reject” button is pushed, colleagues will be alerted via Slack message
Join us to learn more about this new, human-in-the-loop capability, brought to you by Integration Service connectors.
And...
Speakers:
Akshay Agnihotri, Product Manager
Charlie Greenberg, Host
Securing your Kubernetes cluster_ a step-by-step guide to success !KatiaHIMEUR1
Today, after several years of existence, an extremely active community and an ultra-dynamic ecosystem, Kubernetes has established itself as the de facto standard in container orchestration. Thanks to a wide range of managed services, it has never been so easy to set up a ready-to-use Kubernetes cluster.
However, this ease of use means that the subject of security in Kubernetes is often left for later, or even neglected. This exposes companies to significant risks.
In this talk, I'll show you step-by-step how to secure your Kubernetes cluster for greater peace of mind and reliability.
Generating a custom Ruby SDK for your web service or Rails API using Smithyg2nightmarescribd
Have you ever wanted a Ruby client API to communicate with your web service? Smithy is a protocol-agnostic language for defining services and SDKs. Smithy Ruby is an implementation of Smithy that generates a Ruby SDK using a Smithy model. In this talk, we will explore Smithy and Smithy Ruby to learn how to generate custom feature-rich SDKs that can communicate with any web service, such as a Rails JSON API.
2. The Situation
The pace of innovation in life sciences
is at an all time high with unprecedented
scientific development in many areas. It’s just
the beginning of a significant and lasting shift.
With rising M&A costs, increasing pressures on
profitability, biotechs bringing products to
market themselves, and increasing pressures on
profitability, the entire landscape for biopharma
has shifted to an environment that requires
innovative and strategic approaches to
maintain pace.
But how can biopharma companies
sustain growth?
3. To better understand this challenge and determine pathways for success we conducted an extensive
analysis of over 300 M&A deals made by the top 30 biopharma companies between 2010 2021.
The key takeaway:
The traditional approach to fostering growth is no longer sustainable.
The Analysis
The good news is that there are clear pathways that biopharma companies can take
to remain competitive.
7. Assessing the options
Source: Accenture Research Growth Pathways Model 2021.
An analysis of all M&A transactions of top 30 biopharma companies by revenue,
leveraging S&P Cap IQ data. Percentages were calculated based on # of transactions.
Inorganic growth pathways: 2010-2021, number of transactions
36% 34% 16% 14%
Controller
geographic expansion
or vertical integration
Ecosystem
acquisitions of
know-how and
capabilities to
innovate faster
or reach customers
in new ways
Builder
bolt-on-late-stage
asset acquisitions
Architect
early-stage asset
acquisitions often with a
biotechnology platform
Through our analysis, we identified four growth pathways for biopharma companies. By
understanding these pathways, we can better anticipate trends toward innovation and success:
8. 1. Architect:
Shift away from early-stage
assets towards platform-based
deals.
2. Builder:
Fewer asset-based Builder
pathways.
3. Ecosystem and Controller:
More Ecosystem and Controller
pathways thanks to nearly
unlimited funding from VC and
PE as well as increasing
opportunities ex-US.
Growth Pathways Predictions
Source: Accenture Research Growth Pathways Model 2021.
An analysis of all M&A transactions of top 30 biopharma companies by revenue, leveraging S&P Cap IQ data.
Percentages were calculated based on # of transactions.
Inorganic growth pathways: 2010-2021, number of transactions
36% 34% 16% 14%
Fewer late-stage
asset-based Builder
pathways.
35% 15% 25% 25%
Future (illustrative)
Architect
Early-stage asset
acquisitions often
with a biotechnology
platform
Builder
Bolt-on-late-
stage asset
acquisitions
Ecosystem
Acquisitions of
know-how and
capabilities to
innovate faster or
reach customers
in new ways
Controller
Geographic
expansion
or vertical
integration
Shift away from
early-stage assets
and towards
platform-based
deals.
More Ecosystem and Controller
pathways thanks to nearly unlimited
funding from VC and PE as well as
increasing opportunities ex-US.
Predictions
9. 70% of all deals in the last 10 years were
Builder and Architect, but the traditional
Builder approach is becoming less appealing.
The Architect pathway grew by 30% in the
past five years and is expected to continue
to grow.
Ecosystem and Controller pathways account
for only 16% and 14% of M&A deals but we
anticipate that to increase.
Ecosystem will be utilized more often as
partnerships or M&A – to access capabilities
such as AI that accelerate time-to-market.
Controller will become more popular based
on increased opportunities in China
combined with pricing pressures in the US.
Growth Pathways Predictions
Source: Accenture Research Growth Pathways Model 2021.
An analysis of all M&A transactions of top 30 biopharma companies by revenue, leveraging S&P Cap IQ data.
Percentages were calculated based on # of transactions.
Inorganic growth pathways: 2010-2021, number of transactions
36% 34% 16% 14%
Fewer late-stage
asset-based Builder
pathways.
35% 15% 25% 25%
Future (illustrative)
Architect
Early-stage asset
acquisitions often
with a biotechnology
platform
Builder
Bolt-on-late-
stage asset
acquisitions
Ecosystem
Acquisitions of
know-how and
capabilities to
innovate faster or
reach customers
in new ways
Controller
Geographic
expansion
or vertical
integration
Shift away from
early-stage assets
and towards
platform-based
deals.
More Ecosystem and Controller
pathways thanks to nearly unlimited
funding from VC and PE as well as
increasing opportunities ex-US.
Predictions